Vanguard Fiduciary Trust
RGNX icon

Vanguard Fiduciary Trust’s Regenxbio RGNX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04M Buy
337,159
+25,095
+8% +$208K ﹤0.01% 2310
2026
Q1 		$2.62M Buy
+312,064
New +$3.28M ﹤0.01% 2433

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Fiduciary Trust's RGNX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Regenxbio (RGNX) stake by 8% in Q2 2026, buying an estimated $208K and bringing the position to 337,159 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2310.

Vanguard Fiduciary Trust first reported a position in RGNX in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Vanguard Fiduciary Trust held 337,159 shares of Regenxbio worth $4.04M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 25,095 Regenxbio shares in Q2 2026, an estimated $208K.
  • Regenxbio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2310 holding.
  • Vanguard Fiduciary Trust first reported a position in Regenxbio in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.